Clinical Trial Update: 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing safety and efficacy of AADvac1 in patients with mild Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AADvac1

Snippet

Sponsor: Axon Neuroscience SE | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED